BRTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biorestorative Therapies Inc (BRTX).


$9.90M Market Cap.

As of 03/28/2025 5:00 PM ET (MRY) • Disclaimer

BRTX Market Cap. (MRY)


BRTX Shares Outstanding (MRY)


BRTX Assets (MRY)


Total Assets

$12.28M

Total Liabilities

$3.75M

Total Investments

$10.18M

BRTX Income (MRY)


Revenue

$401.00K

Net Income

-$8.98M

Operating Expense

$11.93M

BRTX Cash Flow (MRY)


CF Operations

-$8.23M

CF Investing

$514.53K

CF Financing

$7.38M

BRTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BRTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$12,279,799 (-2.63%)

$12,611,720 (-23.26%)

$16,434,691 (-26.81%)

$22,453,446 (416.52%)

Assets Current

$11,144,221 (-2.16%)

$11,390,526 (-24.71%)

$15,128,490 (-29.53%)

$21,467,908 (573.61%)

Assets Non-Current

$1,135,578 (-7.01%)

$1,221,194 (-6.51%)

$1,306,201 (32.54%)

$985,538 (-15.04%)

Goodwill & Intangible Assets

$623,945 (-12.58%)

$713,692 (-11.17%)

$803,438 (36.24%)

$589,740 (-11.22%)

Shareholders Equity

$8,531,393 (-26.12%)

$11,548,328 (-27.06%)

$15,832,072 (-26.69%)

$21,596,949 (1722.01%)

Property Plant & Equipment Net

$362,936 (-28.49%)

$507,502 (0.94%)

$502,763 (27.03%)

$395,798 (-20.16%)

Cash & Equivalents

$547,890 (-38.05%)

$884,377 (-47.25%)

$1,676,577 (-92.03%)

$21,026,727 (586.11%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$10,184,701 (0.03%)

$10,181,618 (-22.12%)

$13,072,831 (0%)

$0 (0%)

Investments Current

$10,184,701 (0.03%)

$10,181,618 (-22.12%)

$13,072,831 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$188,400 (876.17%)

$19,300 (20.63%)

$16,000 (220.00%)

$5,000 (-70.59%)

Trade & Non-Trade Payables

$483,070 (155.07%)

$189,389 (10.82%)

$170,902 (236.24%)

$50,827 (-57.23%)

Accumulated Retained Earnings (Deficit)

-$155,678,715 (6.81%)

-$167,056,381 (-9.44%)

-$152,640,897 (-13.79%)

-$134,146,128 (-49.31%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$162,317 (-70.58%)

$551,645 (-88.10%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$58,970 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$162,317 (-67.05%)

$492,675 (-89.37%)

Total Liabilities

$3,748,406 (252.50%)

$1,063,392 (76.46%)

$602,619 (-29.64%)

$856,497 (-84.92%)

Liabilities Current

$3,748,406 (252.50%)

$1,063,392 (141.51%)

$440,302 (21.02%)

$363,822 (-65.18%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$162,317 (-67.05%)

$492,675 (-89.37%)

BRTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$401,000 (175.03%)

$145,800 (21.70%)

$119,800 (160.43%)

$46,000 (-40.26%)

Cost of Revenue

$28,072 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$6,579,413 (-41.94%)

$11,331,983 (-27.27%)

$15,580,473 (-39.20%)

$25,624,815 (1212.58%)

Research & Development Expense

$5,348,709 (32.57%)

$4,034,591 (14.84%)

$3,513,352 (381.90%)

$729,058 (-16.85%)

Operating Expenses

$11,928,122 (-22.38%)

$15,366,574 (-19.52%)

$19,093,825 (-27.55%)

$26,353,873 (831.54%)

Interest Expense

$0 (0%)

$0 (0%)

-$11,650 (-100.64%)

$1,815,366 (10.68%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$8,979,381 (37.71%)

-$14,415,484 (22.06%)

-$18,494,769 (58.25%)

-$44,303,295 (-293.01%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$8,979,381 (37.71%)

-$14,415,484 (22.06%)

-$18,494,769 (58.25%)

-$44,303,295 (-293.01%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$8,979,381 (37.71%)

-$14,415,484 (22.06%)

-$18,494,769 (58.25%)

-$44,303,295 (-293.01%)

Weighted Average Shares

$7,763,932 (84.05%)

$4,218,347 (16.60%)

$3,617,858 (204.60%)

$1,187,741 (200.92%)

Weighted Average Shares Diluted

$7,763,932 (84.05%)

$4,218,347 (16.60%)

$3,617,858 (204.60%)

$1,187,741 (200.92%)

Earning Before Interest & Taxes (EBIT)

-$8,979,381 (37.71%)

-$14,415,484 (22.11%)

-$18,506,419 (56.44%)

-$42,487,929 (-341.09%)

Gross Profit

$372,928 (155.78%)

$145,800 (21.70%)

$119,800 (160.43%)

$46,000 (-40.26%)

Operating Income

-$11,555,194 (24.08%)

-$15,220,774 (19.78%)

-$18,974,025 (27.88%)

-$26,307,873 (-855.93%)

BRTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$514,529 (-84.18%)

$3,252,043 (124.13%)

-$13,479,389 (-43866.95%)

-$30,658 (0%)

Net Cash Flow from Financing

$7,379,330 (213.83%)

$2,351,343 (0%)

$0 (0%)

$21,322,683 (324.15%)

Net Cash Flow from Operations

-$8,230,346 (-27.99%)

-$6,430,211 (-9.53%)

-$5,870,761 (-76.30%)

-$3,329,908 (-69.52%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$336,487 (59.30%)

-$826,825 (95.73%)

-$19,350,150 (-207.73%)

$17,962,117 (486.43%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$620,718 (-81.87%)

$3,423,086 (126.25%)

-$13,039,166 (0%)

$0 (0%)

Capital Expenditure

-$106,189 (37.92%)

-$171,043 (35.51%)

-$265,223 (-765.10%)

-$30,658 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$250,000 (-95.47%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$2,351,343 (0%)

$0 (0%)

$21,072,683 (210626.83%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,812,566 (-63.86%)

$7,782,967 (-38.29%)

$12,612,862 (-45.42%)

$23,108,955 (3240.89%)

Depreciation Amortization & Accretion

$340,503 (32.98%)

$256,048 (-8.77%)

$280,667 (36.81%)

$205,152 (35.00%)

BRTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

93.00% (-7.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-2239.20% (77.35%)

-9887.20% (35.96%)

-15438.00% (83.97%)

-96311.50% (-557.87%)

EBITDA Margin

-2154.30% (77.82%)

-9711.50% (36.17%)

-15213.50% (83.45%)

-91919.10% (-646.56%)

Return on Average Equity (ROAE)

-82.00% (28.51%)

-114.70% (-10.93%)

-103.40% (94.04%)

-1734.90% (-1961.48%)

Return on Average Assets (ROAA)

-59.00% (44.96%)

-107.20% (-8.28%)

-99.00% (82.56%)

-567.70% (-10.38%)

Return on Sales (ROS)

-2239.20% (77.35%)

-9887.20% (36.00%)

-15447.80% (83.28%)

-92365.10% (-638.34%)

Return on Invested Capital (ROIC)

-99.80% (29.32%)

-141.20% (51.66%)

-292.10% (72.54%)

-1063.60% (-626.50%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.23 (-142.24%)

-0.51 (5.39%)

-0.54 (-363.79%)

-0.12 (87.99%)

Price to Sales Ratio (P/S)

27.69 (-45.00%)

50.34 (-39.38%)

83.05 (-25.89%)

112.06 (-20.79%)

Price to Book Ratio (P/B)

1.16 (63.61%)

0.71 (11.13%)

0.64 (-9.12%)

0.7 (541.51%)

Debt to Equity Ratio (D/E)

0.44 (377.17%)

0.09 (142.11%)

0.04 (-5.00%)

0.04 (100.94%)

Earnings Per Share (EPS)

-1.16 (66.08%)

-3.42 (33.07%)

-5.11 (86.30%)

-37.3 (-30.60%)

Sales Per Share (SPS)

0.05 (48.57%)

0.04 (6.06%)

0.03 (-15.38%)

0.04 (-80.00%)

Free Cash Flow Per Share (FCFPS)

-1.07 (31.37%)

-1.56 (7.72%)

-1.7 (40.05%)

-2.83 (43.16%)

Book Value Per Share (BVPS)

1.1 (-59.86%)

2.74 (-37.43%)

4.38 (-75.93%)

18.18 (639.08%)

Tangible Assets Book Value Per Share (TABVPS)

1.5 (-46.79%)

2.82 (-34.71%)

4.32 (-76.53%)

18.41 (97.30%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.98 (-139.12%)

-0.41 (-99.51%)

-0.2 (57.20%)

-0.48 (41.73%)

Asset Turnover

0.03 (136.36%)

0.01 (83.33%)

0.01 (0.00%)

0.01 (-82.86%)

Current Ratio

2.97 (-72.25%)

10.71 (-68.82%)

34.36 (-41.77%)

59.01 (1834.66%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$8,336,535 (-26.29%)

-$6,601,254 (-7.58%)

-$6,135,984 (-82.59%)

-$3,360,566 (-71.09%)

Enterprise Value (EV)

$8,448,454 (45.79%)

$5,795,110 (55.44%)

$3,728,093 (-81.59%)

$20,254,900 (159.76%)

Earnings Before Tax (EBT)

-$8,979,381 (37.71%)

-$14,415,484 (22.06%)

-$18,494,769 (58.25%)

-$44,303,295 (-293.01%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$8,638,878 (38.99%)

-$14,159,436 (22.31%)

-$18,225,752 (56.90%)

-$42,282,777 (-345.99%)

Invested Capital

$7,359,558 (-26.04%)

$9,950,259 (-27.25%)

$13,676,691 (1234.57%)

$1,024,802 (-75.64%)

Working Capital

$7,395,815 (-28.38%)

$10,327,134 (-29.69%)

$14,688,188 (-30.40%)

$21,104,086 (885.15%)

Tangible Asset Value

$11,655,854 (-2.04%)

$11,898,028 (-23.88%)

$15,631,253 (-28.51%)

$21,863,706 (493.67%)

Market Capitalization

$9,895,484 (20.83%)

$8,189,565 (-18.94%)

$10,102,480 (-33.36%)

$15,159,555 (7042.14%)

Average Equity

$10,956,431 (-12.81%)

$12,566,324 (-29.78%)

$17,894,675 (600.77%)

$2,553,580 (121.10%)

Average Assets

$15,230,898 (13.25%)

$13,448,520 (-28.00%)

$18,678,812 (139.36%)

$7,803,626 (256.05%)

Invested Capital Average

$8,999,548 (-11.84%)

$10,208,402 (61.12%)

$6,336,034 (58.61%)

$3,994,840 (-39.28%)

Shares

6,919,919 (47.02%)

4,706,917 (28.13%)

3,673,629 (5.17%)

3,492,985 (45322.43%)